M
Marrow
United Kingdom · Fintech · AI
Marrow provides infrastructure that connects AI agents with insurers’ pricing, policy and servicing systems.
Product
Marrow lets insurers make products accessible to AI agents through a common connection to their existing pricing and policy systems. It governs the interaction between agent and insurer, including questions, disclosures and the record of how a policy is sold.
Co-founders Tim Graham and Adam Mesout previously worked at insurer Ki. The London company reports production use with Aviva since March 2026 and is developing the open AMI Standards for agent-led insurance transactions with industry participants.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-seed | $2M | Insurtech Gateway — LeadLeo Capital — ParticipantPortfolio Ventures — ParticipantSeed X — Participant |
Investors
Insurtech GatewayLed Pre-seedLeo CapitalJoined Pre-seedPortfolio VenturesJoined Pre-seedSeed XJoined Pre-seedCoverage
Oct 22, 2026Marrow · Pre-seedSimilar companies
aadsilicoadsilico builds virtual patient populations to help medical-device manufacturers test how implants perform across different anatomies.£10M · Series A
GlanceGlance develops an AI shopping platform that personalises product discovery across smartphones, connected televisions and online brand stores.Undisclosed · Strategic investment
MMoSenseMoSense builds flexible tactile skin and sensing systems for robots.Undisclosed · Angel+